BNP Paribas Financial Markets’s Instil Bio TIL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$54 Hold
7
﹤0.01% 5826
2026
Q1
$58 Hold
7
﹤0.01% 5716
2025
Q4
$77 Sell
7
-3,097
-100% -$45.8K ﹤0.01% 5625
2025
Q3
$55.4K Buy
3,104
+377
+14% +$9.57K ﹤0.01% 4557
2025
Q2
$56.8K Sell
2,727
-505
-16% -$10.6K ﹤0.01% 4212
2025
Q1
$56.1K Buy
3,232
+156
+5% +$3.24K ﹤0.01% 4252
2024
Q4
$58.7K Buy
3,076
+3,011
+4,632% +$91.8K ﹤0.01% 4358
2024
Q3
$4.38K Sell
65
-41
-39% -$965 ﹤0.01% 3850
2024
Q2
$1.09K Sell
106
-72
-40% -$778 ﹤0.01% 3862
2024
Q1
$1.92K Buy
+178
New +$1.95K ﹤0.01% 3818

Other funds holding TIL

BNP Paribas Financial Markets's TIL Position: Q2 2026 in Review

BNP Paribas Financial Markets held its Instil Bio (TIL) position steady in Q2 2026 at 7 shares worth $54. The position accounts for ﹤0.01% of the portfolio, ranked #5826.

BNP Paribas Financial Markets first reported a position in TIL in Q1 2024 and has held it in 10 quarters since. The position peaked at $58.7K in Q4 2024. 19 funds tracked by Wall St. Rank hold TIL as of Q2 2026.

  • BNP Paribas Financial Markets held 7 shares of Instil Bio worth $54 as of Q2 2026.
  • BNP Paribas Financial Markets left its Instil Bio share count unchanged in Q2 2026.
  • Instil Bio made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #5826 holding.
  • BNP Paribas Financial Markets first reported a position in Instil Bio in Q1 2024 and has held it in 10 quarters since.
  • BNP Paribas Financial Markets's Instil Bio position peaked at $58.7K in Q4 2024.
  • 19 funds tracked by Wall St. Rank held Instil Bio as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.